Not for publication or distribution to US persons or in the USA or any other jurisdiction in which offers or sales of securities of RHÖN-KLINIKUM AG are prohibited by law.

RHÖN-KLINIKUM AG today successfully issued a bond (ISIN XS0491047154) with a volume of 
€ 400,000,000 and a maturity of six years. The coupon of the bond is 3.875%, and the issue price was fixed at 99.575%. The bond is being offered with a denomination of € 1,000. The issue proceeds will be used to refinance existing financial liabilities as well as for general corporate purposes.

For the execution of the transaction, Credit Suisse Securities (Europe) Limited, UniCredit Bank AG and WestLB AG were appointed as joint bookrunners. Prior to the transaction, RHÖN-KLINIKUM AG conducted a roadshow where it met approx. 100 investors in Germany, Austria, Switzerland and the UK.

The bond was more than 12 times oversubscribed. As a result of this significant oversubscription, the spread was fixed at 125 bps which was slightly below the initial spread guidance of 130 to 135 bps. In total, some 350 investors from more than 25 countries subscribed. By region, demand was focused on Germany (39%), UK/Ireland (23%) and Austria/Switzerland (14%). More than 50% was placed with fund managers, approx. 35% with banks, savings banks and Volksbanken as well as 6% with insurers.

“With this bond transaction in the international capital market, we have noticeably broadened our financing and investor base. The high demand for our bond underscores RHÖN-KLINIKUM AG’s special standing and leading role in the capital market”, explained Wolfgang Pföhler, chairman of the Board of Management of RHÖN-KLINIKUM AG.

RHÖN-KLINIKUM AG is rated Baa2 by Moody’s with a stable outlook.